Multi-disease development of regenerative cell therapy SB618
A theme covering the development of the individual pipeline candidate SB618, an enhanced-function mesenchymal stem cell therapy, for multiple diseases including peripheral neuropathy, spinal cord injury and multiple sclerosis.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.